Synopsis
The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. “All newborns should be given a birth dose of hepatitis B vaccine,” Offit said.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at The Guardian: Health ↗